Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000552714 | SCV000652545 | uncertain significance | Congenital myasthenic syndrome 12 | 2018-04-25 | criteria provided, single submitter | clinical testing | In summary, this variant is a novel missense change with uncertain impact on protein function. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a GFPT1-related disease. This sequence change replaces tyrosine with cysteine at codon 10 of the GFPT1 protein (p.Tyr10Cys). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and cysteine. |